As a career innovator, entrepreneur, and investor, David co-founded Averin with the vision of bringing forth a new era in health–one powered by technology and that can lead to better outcomes for patients everywhere, faster, and at lower cost.

Prior to Averin, David co-founded over 30 companies across life sciences and sustainability, including 7 that were valued over $1B.  He was previously a General Partner at Flagship Pioneering. 

David has been broadly recognized as a world-leading innovator, having been elected as a Young Global Leader by the World Economic Forum, named an Innovator of the Year by MIT Technology Review from amongst its annual TR35 list, and selected by the U.S. State Department as one of 12 Innovators Reshaping Reality alongside pioneers such as Tim Berners-Lee. He holds over 200 patents and patent applications.

David received his M.D. from Harvard Medical School and his Ph.D. from MIT in biological engineering.  He received a B.S. from MIT in Brain and Cognitive Sciences.